Cargando…

Postoperative Chemotherapy After Surgical Resection of Metachronous Metastases of Colorectal Cancer: A Systematic Review

Currently, 6 months of perioperative or adjuvant chemotherapy (ACT) is a standard treatment option after radical surgical removal of metachronous metastases in patients with metastatic colorectal cancer (CRC). Data show that ACT improves relapse-free survival in such patients, although no difference...

Descripción completa

Detalles Bibliográficos
Autores principales:	Evdokimova, Sevindzh, Kornietskaya, Anna, Bolotina, Larisa, Sidorov, Dmitriy, Kaprin, Andrey
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elmer Press 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990738/ https://www.ncbi.nlm.nih.gov/pubmed/36895991 http://dx.doi.org/10.14740/wjon1568

Ejemplares similares

Endocrine therapy for metastatic solid pseudopapillary neoplasm of the pancreas: A case report
por: Kornietskaya, Anna, et al.
Publicado: (2022)

Surgical resection of synchronous and metachronous lung and liver metastases of colorectal cancers
por: Jeong, Shinseok, et al.
Publicado: (2017)

Complete response to talazoparib in patient with pancreatic adenocarcinoma harboring somatic PALB2 mutation: A case report and literature review
por: Kachmazov, Andrei, et al.
Publicado: (2022)

Adjuvant oxaliplatin- or irinotecan-containing chemotherapy improves overall survival following resection of metachronous colorectal liver metastases
por: Liu, Jin-Hwang, et al.
Publicado: (2010)

Analysis of Prognostic Factors for Resected Synchronous and Metachronous Liver Metastases from Colorectal Cancer
por: Bartolini, Ilenia, et al.
Publicado: (2018)

Metachronous Ovarian Metastases Following Resection of the Primary Gastric Cancer
por: Jun, Si-Youl, et al.
Publicado: (2011)

Curative Resection for Metachronous Pulmonary Metastases from Colorectal Cancer: Analysis of Survival Rates and Prognostic Factors
por: Ihn, Myong Hoon, et al.
Publicado: (2017)

Hepatic Resection is Safe for Metachronous Hepatic Metastases from Ovarian Cancer
por: Niu, Guang-cai, et al.
Publicado: (2012)

Resection of colorectal liver metastases following neoadjuvant chemotherapy
por: Chiappa, A, et al.
Publicado: (2007)

Incidence and Survival in Synchronous and Metachronous Liver Metastases From Colorectal Cancer
por: Reboux, Noémi, et al.
Publicado: (2022)

Synchronous and metachronous colorectal liver metastases: impact of primary tumor location on patterns of recurrence and survival after hepatic resection
por: Garajova, Ingrid, et al.
Publicado: (2021)

Hepatectomy for metachronous colorectal liver metastases following complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal metastases: a report of three cases
por: Ito, Kyoji, et al.
Publicado: (2019)

Percutaneous Radiofrequency Ablation for Metachronous Hepatic Metastases after Curative Resection of Pancreatic Adenocarcinoma
por: Lee, So Jung, et al.
Publicado: (2020)

Indocyanine green navigation in minimally invasive resection of multiple metachronous pulmonary metastases of hepatoblastoma
por: Delgado‐Miguel, Carlos, et al.
Publicado: (2023)

Systematic Review With Network Meta-Analysis: Adjuvant Chemotherapy for Resected Colorectal Liver Metastases
por: Zhu, Gui-Qi, et al.
Publicado: (2015)

Surgical Resection for Lung Metastases from Colorectal Cancer
por: Kim, Hyung Jin, et al.
Publicado: (2010)

Surgical resection of metachronous hepatic metastases from gastric cancer improves long-term survival: A population-based study
por: Li, Szu-Chin, et al.
Publicado: (2017)

Effect of Neoadjuvant Chemotherapy in Patients with Resectable Colorectal Liver Metastases
por: Zhu, Dexiang, et al.
Publicado: (2014)

Metachronous advanced neoplasia after submucosal invasive colorectal cancer resection
por: Minamide, Tatsunori, et al.
Publicado: (2021)

A case of successfully resected metachronous gastric and gallbladder metastases from pancreatic body cancer
por: Takahashi, Makoto, et al.
Publicado: (2019)

9-ING-41, a Small Molecule Inhibitor of GSK-3β, Potentiates the Effects of Chemotherapy on Colorectal Cancer Cells
por: Poloznikov, Andrey, et al.
Publicado: (2021)

The role of neoadjuvant chemotherapy for resectable colorectal liver metastases: a systematic review and meta-analysis
por: Liu, Wei, et al.
Publicado: (2016)

Incidence and management of patients with colorectal cancer and synchronous and metachronous colorectal metastases: a population‐based study
por: Väyrynen, V., et al.
Publicado: (2020)

Clinicopathological features and outcome in advanced colorectal cancer patients with synchronous vs metachronous metastases
por: Mekenkamp, L J M, et al.
Publicado: (2010)

Differences in clinical characteristics and mutational pattern between synchronous and metachronous colorectal liver metastases
por: Zheng, Peng, et al.
Publicado: (2018)

Clinicopathologic and Prognostic Association of GRP94 Expression in Colorectal Cancer with Synchronous and Metachronous Metastases
por: Yun, Sumi, et al.
Publicado: (2021)

Survival Outcomes After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy in Patients with Synchronous Versus Metachronous Onset of Peritoneal Metastases of Colorectal Carcinoma
por: Dietz, Michelle V., et al.
Publicado: (2022)

Multielectrode Radiofrequency Ablation for Resectable Metachronous Liver Metastasis from Colorectal Cancer
por: Cheng, Hou-Ying, et al.
Publicado: (2021)

Peri-operative chemotherapy in the management of resectable colorectal cancer pulmonary metastases
por: Hawkes, Eliza A, et al.
Publicado: (2012)

Prognostic impact of additive chemotherapy after curative resection of metachronous colorectal liver metastasis: a single-centre retrospective study
por: Kelm, Matthias, et al.
Publicado: (2021)

The different clonal origins of metachronous and synchronous metastases
por: Gofrit, Ofer N., et al.
Publicado: (2023)

Metachronous Peritoneal Metastases After Adjuvant Chemotherapy are Associated with Poor Outcome After Cytoreduction and HIPEC
por: Sluiter, Nina R., et al.
Publicado: (2018)

Postoperative chemotherapy with single-agent fluoropyrimidines after resection of colorectal cancer liver metastases: a meta-analysis of randomised trials
por: Mauri, Davide, et al.
Publicado: (2018)

Long-term survival after surgical resection of metachronous lung, brain and thyroid gland metastases from rectal cancer: A case report
por: Rifu, Kazuma, et al.
Publicado: (2021)

Surgical resection of hepatic metastases from colorectal cancer: A systematic review of published studies
por: Simmonds, P C, et al.
Publicado: (2006)

Neoadjuvant chemotherapy for patients with resectable colorectal cancer liver metastases: A systematic review and meta-analysis
por: Zhang, Yue, et al.
Publicado: (2021)

Postoperative Fractionated Stereotactic Radiosurgery to the Tumor Bed for Surgically Resected Brain Metastases
por: Cleary, Ryan K, et al.
Publicado: (2017)

Is neoadjuvant chemotherapy necessary for patients with initially resectable colorectal liver metastases in the era of effective chemotherapy?
por: Son, Sang-Yong, et al.
Publicado: (2011)

Synchronous and metachronous liver metastases in patients with colorectal cancer—towards a clinically relevant definition
por: Engstrand, Jennie, et al.
Publicado: (2019)

Prognostic potential of whole exome sequencing in the clinical management of metachronous colorectal cancer liver metastases
por: Heczko, Lucie, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mbjml0pc022rpq7h8e845ugapi